FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2513040800> ?p ?o ?g. }

• W2513040800 endingPage "2307" @default.
• W2513040800 startingPage "2298" @default.
• W2513040800 abstract "The aim of this work was to study the potential long-term impact of a 7.8 years intensified, multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria in terms of gained years of life and years free from incident cardiovascular disease.The original intervention (mean treatment duration 7.8 years) involved 160 patients with type 2 diabetes and microalbuminuria who were randomly assigned (using sealed envelopes) to receive either conventional therapy or intensified, multifactorial treatment including both behavioural and pharmacological approaches. After 7.8 years the study continued as an observational follow-up with all patients receiving treatment as for the original intensive-therapy group. The primary endpoint of this follow-up 21.2 years after intervention start was difference in median survival time between the original treatment groups with and without incident cardiovascular disease. Non-fatal endpoints and causes of death were adjudicated by an external endpoint committee blinded for treatment allocation.Thirty-eight intensive-therapy patients vs 55 conventional-therapy patients died during follow-up (HR 0.55 [95% CI 0.36, 0.83], p = 0.005). The patients in the intensive-therapy group survived for a median of 7.9 years longer than the conventional-therapy group patients. Median time before first cardiovascular event after randomisation was 8.1 years longer in the intensive-therapy group (p = 0.001). The hazard for all microvascular complications was decreased in the intensive-therapy group in the range 0.52 to 0.67, except for peripheral neuropathy (HR 1.12).At 21.2 years of follow-up of 7.8 years of intensified, multifactorial, target-driven treatment of type 2 diabetes with microalbuminuria, we demonstrate a median of 7.9 years of gain of life. The increase in lifespan is matched by time free from incident cardiovascular disease.ClinicalTrials.gov registration no. NCT00320008.The study was funded by an unrestricted grant from Novo Nordisk A/S." @default.
• W2513040800 created "2016-09-16" @default.
• W2513040800 creator A5017888674 @default.
• W2513040800 creator A5021753819 @default.
• W2513040800 creator A5041006587 @default.
• W2513040800 creator A5042890915 @default.
• W2513040800 creator A5066665434 @default.
• W2513040800 creator A5071367797 @default.
• W2513040800 creator A5085592050 @default.
• W2513040800 date "2016-08-16" @default.
• W2513040800 modified "2023-10-14" @default.
• W2513040800 title "Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial" @default.
• W2513040800 cites W146577346 @default.
• W2513040800 cites W1469193822 @default.
• W2513040800 cites W1520609538 @default.
• W2513040800 cites W1553537184 @default.
• W2513040800 cites W1973491874 @default.
• W2513040800 cites W1976158888 @default.
• W2513040800 cites W1996242285 @default.
• W2513040800 cites W2023984564 @default.
• W2513040800 cites W2026480246 @default.
• W2513040800 cites W2097225786 @default.
• W2513040800 cites W2102420102 @default.
• W2513040800 cites W2102924526 @default.
• W2513040800 cites W2124909544 @default.
• W2513040800 cites W2125468958 @default.
• W2513040800 cites W2139634859 @default.
• W2513040800 cites W2140887581 @default.
• W2513040800 cites W2141713511 @default.
• W2513040800 cites W2147222003 @default.
• W2513040800 cites W2153552938 @default.
• W2513040800 cites W2170271198 @default.
• W2513040800 cites W2171294019 @default.
• W2513040800 cites W2172157568 @default.
• W2513040800 cites W2206266436 @default.
• W2513040800 cites W2306356166 @default.
• W2513040800 cites W2321638628 @default.
• W2513040800 cites W2589131700 @default.
• W2513040800 cites W3171237122 @default.
• W2513040800 cites W4244540230 @default.
• W2513040800 doi "https://doi.org/10.1007/s00125-016-4065-6" @default.
• W2513040800 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5506099" @default.
• W2513040800 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27531506" @default.
• W2513040800 hasPublicationYear "2016" @default.
• W2513040800 type Work @default.
• W2513040800 sameAs 2513040800 @default.
• W2513040800 citedByCount "353" @default.
• W2513040800 countsByYear W25130408002016 @default.
• W2513040800 countsByYear W25130408002017 @default.
• W2513040800 countsByYear W25130408002018 @default.
• W2513040800 countsByYear W25130408002019 @default.
• W2513040800 countsByYear W25130408002020 @default.
• W2513040800 countsByYear W25130408002021 @default.
• W2513040800 countsByYear W25130408002022 @default.
• W2513040800 countsByYear W25130408002023 @default.
• W2513040800 crossrefType "journal-article" @default.
• W2513040800 hasAuthorship W2513040800A5017888674 @default.
• W2513040800 hasAuthorship W2513040800A5021753819 @default.
• W2513040800 hasAuthorship W2513040800A5041006587 @default.
• W2513040800 hasAuthorship W2513040800A5042890915 @default.
• W2513040800 hasAuthorship W2513040800A5066665434 @default.
• W2513040800 hasAuthorship W2513040800A5071367797 @default.
• W2513040800 hasAuthorship W2513040800A5085592050 @default.
• W2513040800 hasBestOaLocation W25130408001 @default.
• W2513040800 hasConcept C126322002 @default.
• W2513040800 hasConcept C134018914 @default.
• W2513040800 hasConcept C141071460 @default.
• W2513040800 hasConcept C168563851 @default.
• W2513040800 hasConcept C203092338 @default.
• W2513040800 hasConcept C207103383 @default.
• W2513040800 hasConcept C23131810 @default.
• W2513040800 hasConcept C2779134260 @default.
• W2513040800 hasConcept C2781203188 @default.
• W2513040800 hasConcept C2910068830 @default.
• W2513040800 hasConcept C44249647 @default.
• W2513040800 hasConcept C555293320 @default.
• W2513040800 hasConcept C71924100 @default.
• W2513040800 hasConceptScore W2513040800C126322002 @default.
• W2513040800 hasConceptScore W2513040800C134018914 @default.
• W2513040800 hasConceptScore W2513040800C141071460 @default.
• W2513040800 hasConceptScore W2513040800C168563851 @default.
• W2513040800 hasConceptScore W2513040800C203092338 @default.
• W2513040800 hasConceptScore W2513040800C207103383 @default.
• W2513040800 hasConceptScore W2513040800C23131810 @default.
• W2513040800 hasConceptScore W2513040800C2779134260 @default.
• W2513040800 hasConceptScore W2513040800C2781203188 @default.
• W2513040800 hasConceptScore W2513040800C2910068830 @default.
• W2513040800 hasConceptScore W2513040800C44249647 @default.
• W2513040800 hasConceptScore W2513040800C555293320 @default.
• W2513040800 hasConceptScore W2513040800C71924100 @default.
• W2513040800 hasFunder F4320322436 @default.
• W2513040800 hasIssue "11" @default.
• W2513040800 hasLocation W25130408001 @default.
• W2513040800 hasLocation W25130408002 @default.
• W2513040800 hasLocation W25130408003 @default.
• W2513040800 hasLocation W25130408004 @default.
• W2513040800 hasLocation W25130408005 @default.
• W2513040800 hasOpenAccess W2513040800 @default.

• next